Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.

[1]  E. Braunwald,et al.  Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators. , 1996, American heart journal.

[2]  K. Lee,et al.  Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. , 1996, Circulation.

[3]  J Col,et al.  Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. , 1995, Circulation.

[4]  R. Becker,et al.  Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: a coronary care unit experience. , 1994, American heart journal.

[5]  D. Reich,et al.  Comparison of bedside coagulation monitoring tests with standard laboratory tests in patients after cardiac surgery. , 1993, Anesthesia and analgesia.

[6]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[7]  M. Simoons,et al.  Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA). , 1992, Journal of the American College of Cardiology.

[8]  J. Hsia,et al.  Heparin-induced prolongation of partial thromboplastin time after thrombolysis: relation to coronary artery patency. HART Investigators. , 1992, Journal of the American College of Cardiology.

[9]  D. Sane,et al.  Exploration of rapid bedside monitoring of coagulation and fibrinolysis parameters during thrombolytic therapy. , 1992 .

[10]  C. Corke,et al.  A Comparison of Five Devices for the Bedside Monitoring of Heparin Therapy , 1991, Anaesthesia and intensive care.

[11]  K. Mann,et al.  Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. , 1991, Annals of internal medicine.

[12]  E. Topol,et al.  Adjuncts to thrombolysis for myocardial reperfusion. , 1991, Annals of internal medicine.

[13]  D. Adler,et al.  Measurement of the activated partial thromboplastin time from a capillary (fingerstick) sample of whole blood. A new method for monitoring heparin therapy. , 1991, American journal of clinical pathology.

[14]  P N Valenstein,et al.  Sensitivity, specificity, and reproducibility of four measures of laboratory turnaround time. , 1989, American journal of clinical pathology.

[15]  D. Doyle,et al.  Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. , 1989, The New England journal of medicine.

[16]  A. Shojania,et al.  The variations between heparin sensitivity of different lots of activated partial thromboplastin time reagent produced by the same manufacturer. , 1988, American journal of clinical pathology.

[17]  D. Mungall,et al.  A novel whole blood capillary technic for measuring the prothrombin time. , 1987, American journal of clinical pathology.

[18]  M. Parker,et al.  Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction. , 1987, The American journal of cardiology.

[19]  T. Bjornsson,et al.  Variability in heparin sensitivity of APTT reagents. , 1986, American journal of clinical pathology.

[20]  E. Gottfried,et al.  The Effects of Inaccurate Blood Sample Volume on Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) , 1982, Thrombosis and Haemostasis.

[21]  J. Brandt,et al.  Laboratory monitoring of heparin. Effect of reagents and instruments on the activated partial thromboplastin time. , 1981, American journal of clinical pathology.

[22]  M. Corn,et al.  Control of Heparin Therapy With Activated Partial Thromboplastin Times , 1967 .